Special situations
About 30% of people diagnosed with ulcerative colitis (UC) have inflammation confined to the rectum, a subtype called ulcerative proctitis. If that describes you, you have probably noticed that most UC resources lump all disease extents together, as if someone with pancolitis and someone with proctitis face identical challenges. They do not. Ulcerative proctitis treatment follows a different playbook, starting with topical therapies rather than systemic drugs, and the questions you carry (will it spread? why does everyone act like this is no big deal?) deserve direct answers.
Why Topical Mesalamine Is the Starting Point
When inflammation is limited to the rectum, medication delivered directly to the affected tissue works better than pills that have to travel through your entire digestive tract. That is why current guidelines from the American College of Gastroenterology recommend rectal mesalamine (a 5-aminosalicylic acid, or 5-ASA) at 1 gram daily as first-line therapy for mild to moderate ulcerative proctitis. Suppositories are the preferred delivery method because the medication stays concentrated in the rectum, right where the inflammation lives. Enemas, by contrast, tend to coat higher up into the sigmoid colon, which is useful for left-sided colitis but unnecessarily broad for isolated proctitis.
This topical-first approach has real advantages. You avoid the systemic side effects that come with oral medications, and research consistently shows that rectal mesalamine produces higher remission rates in proctitis than oral mesalamine alone. Many patients achieve remission within three to six weeks of daily suppository use.
Getting the Most Out of Suppositories
Mesalamine suppositories work well, but technique matters. According to Cleveland Clinic guidance, you should have a bowel movement before insertion, then lie on your left side with your right knee bent. Insert the suppository pointed end first, and remain lying down for several minutes afterward. The goal is to retain the suppository for at least one to three hours so the medication has time to absorb into the rectal mucosa. Using them at bedtime makes retention easier, since you are lying still for hours.
A few practical notes: handle the suppository as little as possible before insertion, because body heat melts the coating. If retention is genuinely difficult, talk to your gastroenterologist about mesalamine foam or liquid enemas as alternatives. Some patients also find that a small amount of lubricating gel on the tip makes insertion more comfortable. These are details that rarely come up in a rushed clinic visit, but they can be the difference between a treatment that works and one you abandon out of frustration.
Will Your Proctitis Spread?
This is the question that quietly follows many proctitis patients through their daily life. The honest answer is that it might. A systematic review and meta-analysis found that roughly 18% of ulcerative proctitis patients experience proximal extension within five years, and about 31% do within ten years. That means the majority of proctitis patients do not see their disease spread, but a meaningful portion do, and knowing the risk factors can help you and your GI stay ahead of it.
Research from IBD referral centers has identified several factors associated with higher risk of extension: younger age at diagnosis (under 40), a higher Mayo Endoscopic Score at your initial colonoscopy, more frequent flares in your first year, and early need for oral corticosteroids. A Polish retrospective study also found that high stress levels correlated with extension risk, though the mechanism behind that link is still being studied. If any of these risk factors apply to you, more frequent monitoring with your GI is reasonable.
When Topical Therapy Alone Is Not Enough
For patients who do not respond to rectal mesalamine after an adequate trial, the next steps typically involve adding oral mesalamine or switching to rectal corticosteroids (like budesonide foam or beclomethasone suppositories). The 2025 ACG guidelines also suggest tacrolimus suppositories as an option for refractory proctitis before escalating to systemic immunosuppressants or biologics.
The key signal that your treatment needs to change is persistent symptoms despite consistent topical therapy. If you are using your suppository daily and still experiencing bleeding, urgency, or tenesmus (that frustrating feeling of incomplete evacuation) after six to eight weeks, bring that data to your gastroenterologist. This is where symptom tracking becomes especially valuable, because "it's not really getting better" is harder for your GI to act on than "I've had bleeding on 18 of the last 30 days and urgency scores averaging 6 out of 10."
The Emotional Weight of a "Mild" Diagnosis
One of the most isolating aspects of ulcerative proctitis is hearing, from doctors and from other UC patients alike, that you have the "mild" or "lucky" form of the disease. Proctitis can involve daily rectal bleeding, constant urgency, painful tenesmus, and the background anxiety of wondering whether your disease will progress. None of that feels mild when you are living it.
The Crohn's & Colitis UK community has documented how people with IBD often struggle to explain their condition to family and friends, and this challenge is amplified when your own diagnosis carries a label that sounds minor. Your symptoms are real, your concerns about progression are valid, and your treatment deserves the same attention as any other UC subtype.
Track Your Proctitis Symptoms With Aidy
Track your proctitis symptoms daily with Aidy, especially urgency and bleeding patterns. This data helps your GI determine whether topical therapy alone is controlling your disease or if you need to escalate. A clear record of symptom frequency, severity, and response to treatment gives you concrete evidence to bring to every appointment, turning subjective impressions into actionable clinical information.